Tumor progression is associated with a significant decrease in the expression of the endostatin precursor collagen XVIII in human hepatocellular carcinomas
O. Musso et al., Tumor progression is associated with a significant decrease in the expression of the endostatin precursor collagen XVIII in human hepatocellular carcinomas, CANCER RES, 61(1), 2001, pp. 45-49
Endostatin inhibits angiogenesis and tumor growth in mice. The role of its
endogenous precursor collagen XVIII in human cancer is unknown. In normal t
issues, two variants of collagen XVIII, namely, the short and long forms re
gulate tissue specificity, the long form being almost exclusively expressed
by hepatocytes in the liver. We analyzed RNA arrays from 57 hepatocellular
carcinomas (HCCs) with common and variant specific probes and investigated
the relationships between collagen XVIII expression and angiogenesis by me
asuring the CD34-positive microvessel density. Low collagen XVIII expressio
n by tumor hepatocytes was associated with large tumor size (r, -0.63; P <
0.001) and replacement of trabeculae with pseudoglandular-solid architectur
e (<chi>(2), 28; P < 0.001), which indicate tumor progression. Tumors expre
ssing the highest collagen XVIII levels were smaller and had lower microves
sel density (P = 0.01) than those expressing moderate levels; and HCCs with
the lowest collagen XVIII levels approached a plateau of microvessel densi
ty, which indicated that a decrease in collagen XVIII expression is associa
ted with angiogenesis in primary liver cancer. HCCs recurring within 2 year
s of resection showed 2.2-fold lower collagen XVIII mRNA than nonrecurring
ones (P = 0.02). The findings relied on the hepatocyte-specific long form.
Thus, the endogenous expression of the endostatin precursor decreases along
with tumor progression in HCCs.